Analyst Ratings for Orchard Therapeutics (ORTX)

ORTX Rating Summary

ORTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ORTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $14.14 (+396.2%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/2/2021 JPMorgan
» Updated 6/30/2021
Anupam Rama New Coverage Overweight
(N/A)
14.00
(15.00)
6.97
(2.85)
-59.11% Details
3/2/2021 Stifel Dae Gon Ha New Coverage Buy
(N/A)
12.00
(N/A)
6.97
(2.85)
-59.11% Details
Like ORTX Ratings? Also take a look at ERYP, CYRX, AXGT, ALBO

ORTX Ratings News